Omzet 2024 * | 611 mln. 570 mln. | Omzet 2025 * | 705 mln. 657 mln. | Marktkapitalisatie | 2,48 mld. 2,31 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 117 mln. 109 mln. | Nettowinst (verlies) 2025 * | 183 mln. 171 mln. | EV/omzet 2024 * | 3,21 x |
Nettoliquiditeiten 2024 * | 521 mln. 486 mln. | Nettoliquiditeiten 2025 * | 621 mln. 579 mln. | EV/omzet 2025 * | 2,64 x |
K/w-verhouding 2024 * |
23,4
x | K/w-verhouding 2025 * |
15,2
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 68,25% |
Recentste transcriptie over Corcept Therapeutics
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 13-05-98 |
Atabak Mokari
DFI | Director of Finance/CFO | 47 | 01-03-21 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-06-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 13-05-98 |
Gregg Alton
BRD | Director/Board Member | 58 | 12-03-20 |
George Baker
BRD | Director/Board Member | 81 | 01-01-99 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,25% | 704 mld. | |
+28,59% | 577 mld. | |
-3,55% | 348 mld. | |
+18,16% | 327 mld. | |
+4,36% | 288 mld. | |
+14,81% | 234 mld. | |
+4,93% | 198 mld. | |
-9,78% | 194 mld. | |
-3,69% | 147 mld. |